Health Affairs Blog: Addressing Generic Drug Unaffordability And Shortages By Globalizing The Market For Old Drugs
Alfred Engelberg, retired intellectual property lawyer and philanthropist; Jerry Avorn, professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital; and Aaron Kesselheim, assistant professor of medicine at Harvard Medical School and faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital, discuss the creation of a global market for generic drugs “to maximize competition, normalize prices, and put those who improperly thrive on market failures out of business…” (2/23).